Brain tumors represent the leading cause of cancer-related deaths among children in the United States age 14 and younger, and nearly 14,000 children are estimated to be living with a primary brain tumor, according to the National Brain Tumor Society. The organization estimates that more than 4,000 new childhood brain tumors will be diagnosed in 2022.
BBI’s Dr. Sarah Leary, who leads the multi-disciplinary Brain Tumor Program at Seattle Children’s, and her colleague Dr. Erin Crotty, a pediatric neuro-oncologist in the program, are committed to lowering that number. With Crotty’s new one-year, $100,000 Emerging Scientist Award from the Children’s Cancer Research Fund (CCRF) enabling the expansion of their existing work supported by BBI, they and others at Seattle Children’s are making substantial progress toward their shared commitment.
